High Tide Inc., a retail-oriented cannabis corporation based in Alberta, Canada, specializes in the manufacturing and distribution of smoking accessories, catering to both wholesale and retail clients. Additionally, the company engages in the sale of cannabis products directly to retail consumers, serving a primarily Canadian customer base. High Tide operates within the Health Care sector, specifically under the Pharmaceuticals industry, and is listed on the TSX Venture Exchange.
As of December 15, 2025, High Tide’s stock closed at CAD 3.98. This price is situated below the 52-week low of CAD 2.37, recorded on April 7, 2025, and above the 52-week high of CAD 5.59, noted on September 18, 2025. The stock’s current price is approximately 33% below its 52-week peak, indicating a modest decline from recent highs but remaining significantly above its lowest point over the past year.
The company’s market capitalization stands at CAD 325.8 million. Financially, High Tide exhibits a price-to-earnings (P/E) ratio of -31.36, reflecting negative earnings. This negative P/E ratio suggests that the company is not currently profitable. Additionally, the price-to-book (P/B) ratio is 2.47, indicating a valuation relative to the company’s book value.
In terms of recent corporate activities, High Tide has not issued any updates beyond the announcement on December 5, 2025, which detailed the opening of three new Canna Cabana stores. This expansion reflects the company’s ongoing efforts to grow its retail presence within the Canadian market.
Overall, while High Tide’s financial metrics indicate challenges in profitability, the company’s strategic expansion through new store openings suggests a focus on growth and market penetration within the cannabis retail sector.